Funding for this research was provided by:
Swiss Cancer League/Swiss Cancer Research (KFS-3008-08-2012)
Nursing Science Foundation, Switzerland
Federal Office of Public Health, Switzerland
Start Stipend Award, PhD Program in Health Sciences, University of Basel
Received: 19 October 2016
Accepted: 29 January 2018
First Online: 16 February 2018
Ethics approval and consent to participate
: Human Research Ethics Committees from the 11 Swiss cantons in which the study took place approved the PELICAN study (leading committee: Kantonale Ethikkommission Zürich, KEK ZH Nr. 2012-0537). Parents of eligible deceased children were informed and invited to participate in the study by the former treating team, who also acted as gatekeeper as needed. Participation was entirely voluntary and written informed consent was obtained from all participants.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.